The company claims its Fertilo system can mature eggs outside the body using 80% fewer hormonal injections than typical ...
The U.S. Food and Drug Administration said it approved Boston-based Vertex Pharmaceuticals' Journavx for short-term pain that ...
The drug offered more relief than a placebo in clinical trials, though it does not appear more effective than other pain ...
February is observed as American Heart Month, a period dedicated to raising awareness about heart health. The first American Heart ...
DelveInsight’s, “Metastatic Breast Cancer Pipeline Insight” report provides comprehensive insights about 100+ companies and ...
The greenlight for Journavx (suzetrigine), which comes on the heels of a $7.4 billion opioid settlement, could spark momentum ...
The Vertex drug is a milestone after a long history of unsuccessful efforts to develop painkillers without the addictive ...
US-based Aethlon Medical has treated the first subject with its Hemopurifier investigational device in its Australian cancer ...
In the Opportunity Research report, analyst Rob Goldman reviews clinical and preclinical data on OKYO's lead candidate, the Company's inherent first-mover opportunities in the industry, upcoming ...
Gameto Announces FDA IND Clearance for Fertilo, the First iPSC-Based Therapy to Enter U.S. Phase 3 Clinical Trials ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback